Sign in

CIK 0001833141 · <br>Emerging growth company

Helus Pharma Inc.

Sign in to watch
Ticker
HELP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
British Columbia, Canada
Entity type
other
Phone
(908) 764-8385
Business address
100 KING STREET WEST, SUITE 5600, TORONTO, Ontario, Canada
Former names
CYBIN INC.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 248,000 shares (grant or award)
  9. 4 Open-market buy Chief Financial Officer bought 3,000 shares at $12.91 ($38,730)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Chief Growth Officer acquired 248,000 shares (grant or award)
  12. 4 Open-market buy Chief Executive Officer bought 100,000 shares at $13.47 ($1,347,050)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Chief Growth Officer bought 100,000 shares at $12.47 ($1,247,190)
  15. 4 Open-market buy Chief Growth Officer bought 100,000 shares at $12.47 ($1,247,190)
  16. 4 Open-market buy Executive Chair bought 100,000 shares at $12.39 ($1,238,670)
  17. 4 Open-market buy Executive Chair bought 100,000 shares at $12.09 ($1,208,900)
  18. 4 Open-market buy Chief Growth Officer bought 100,000 shares at $11.78 ($1,178,280)
  19. 4 Open-market buy Executive Chair bought 95,000 shares at $11.81 ($1,121,475)
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 22 filings